March 4, 2025 - 03:18

Microchip Technology is set to reduce its workforce by 2,000 positions, which represents approximately 9% of its total employees. This significant move comes in response to a noticeable decline in demand within the automotive sector. The company has outlined a restructuring plan that will incur costs ranging from $30 to $40 million. However, it anticipates achieving annual savings between $90 and $100 million through operational efficiencies, alongside an additional $25 million in savings resulting from the workforce reductions.
As part of this restructuring, Microchip Technology will also close several of its manufacturing plants. This decision underscores the challenges faced by the semiconductor industry, particularly in light of fluctuating market demands. The company aims to streamline its operations in order to adapt to these changing conditions, ensuring its long-term viability and competitive edge in the market. The layoffs and plant closures mark a significant shift for Microchip Technology as it navigates these turbulent economic waters.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...